102 related articles for article (PubMed ID: 20176598)
1. Chronic inflammatory demyelinating polyneuropathy responsive to mycophenolate mofetil therapy.
Bedi G; Brown A; Tong T; Sharma KR
J Neurol Neurosurg Psychiatry; 2010 Jun; 81(6):634-6. PubMed ID: 20176598
[TBL] [Abstract][Full Text] [Related]
2. [A case of intravenous immunoglobulin-dependent chronic inflammatory demyelinating polyneuropathy of pure motor form responsive to mycophenolate mofetil therapy].
Arai M
Rinsho Shinkeigaku; 2016 Oct; 56(10):698-701. PubMed ID: 27680225
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of mycophenolate mofetil in patients with chronic immune demyelinating polyneuropathy.
Gorson KC; Amato AA; Ropper AH
Neurology; 2004 Aug; 63(4):715-7. PubMed ID: 15326250
[TBL] [Abstract][Full Text] [Related]
4. Treatment of Guillain-Barré syndrome with mycophenolate mofetil: a pilot study.
Garssen MP; van Koningsveld R; van Doorn PA; Merkies IS; Scheltens-de Boer M; van Leusden JA; van Schaik IN; Linssen WH; Visscher F; Boon AM; Faber CG; Meulstee J; Prick MJ; van den Berg LH; Franssen H; Hiel JA; van den Bergh PY; Sindic CJ
J Neurol Neurosurg Psychiatry; 2007 Sep; 78(9):1012-3. PubMed ID: 17702789
[No Abstract] [Full Text] [Related]
5. Mycophenolate mofetil versus azathioprine in patients with chronic active ulcerative colitis: a 12-month pilot study.
Orth T; Peters M; Schlaak JF; Krummenauer F; Wanitschke R; Mayet WJ; Galle PR; Neurath MF
Am J Gastroenterol; 2000 May; 95(5):1201-7. PubMed ID: 10811328
[TBL] [Abstract][Full Text] [Related]
6. Mycophenolate mofetil and neurological diseases.
Vermersch P; Stojkovic T; de Seze J
Lupus; 2005; 14 Suppl 1():s42-5. PubMed ID: 15803931
[TBL] [Abstract][Full Text] [Related]
7. Mycophenolate mofetil for the treatment of refractory, acute, cellular renal transplant rejection. The Mycophenolate Mofetil Renal Refractory Rejection Study Group.
Transplantation; 1996 Mar; 61(5):722-9. PubMed ID: 8607174
[TBL] [Abstract][Full Text] [Related]
8. Mycophenolate mofetil for the treatment of a first acute renal allograft rejection: The Mycophenolate Mofetil Acute Renal Rejection Study Group.
Transplantation; 1998 Jan; 65(2):235-41. PubMed ID: 9458021
[TBL] [Abstract][Full Text] [Related]
9. Mycophenolate mofetil is safe, well tolerated, and preserves lung function in patients with connective tissue disease-related interstitial lung disease.
Swigris JJ; Olson AL; Fischer A; Lynch DA; Cosgrove GP; Frankel SK; Meehan RT; Brown KK
Chest; 2006 Jul; 130(1):30-6. PubMed ID: 16840379
[TBL] [Abstract][Full Text] [Related]
10. Effect and safety of mycophenolate mofetil in chronic pulmonary sarcoidosis: a retrospective study.
Brill AK; Ott SR; Geiser T
Respiration; 2013; 86(5):376-83. PubMed ID: 23295253
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of mycophenolate mofetil vs. methotrexate for the treatment of chronic plaque psoriasis.
Akhyani M; Chams-Davatchi C; Hemami MR; Fateh S
J Eur Acad Dermatol Venereol; 2010 Dec; 24(12):1447-51. PubMed ID: 20384673
[TBL] [Abstract][Full Text] [Related]
12. Mycophenolic acid 12-hour area under the curve in de novo liver transplant patients given mycophenolate mofetil at fixed versus concentration-controlled doses.
Kamar N; Marquet P; Gandia P; Muscari F; Lavayssière L; Esposito L; Guitard J; Canivet C; Peron JM; Alric L; Suc B; Saint-Marcoux F; Rostaing L
Ther Drug Monit; 2009 Aug; 31(4):451-6. PubMed ID: 19531983
[TBL] [Abstract][Full Text] [Related]
13. Mycophenolate mofetil is a highly effective and safe immunosuppressive agent for the treatment of uveitis : a retrospective analysis of 106 patients.
Siepmann K; Huber M; Stübiger N; Deuter C; Zierhut M
Graefes Arch Clin Exp Ophthalmol; 2006 Jul; 244(7):788-94. PubMed ID: 16163494
[TBL] [Abstract][Full Text] [Related]
14. Different efficacy of mycophenolate mofetil as salvage treatment for acute and chronic GVHD after allogeneic stem cell transplant.
Kim JG; Sohn SK; Kim DH; Lee NY; Suh JS; Lee KS; Lee KB
Eur J Haematol; 2004 Jul; 73(1):56-61. PubMed ID: 15182339
[TBL] [Abstract][Full Text] [Related]
15. Long-term mycophenolate mofetil monotherapy in combination with calcineurin inhibitors for chronic renal dysfunction after liver transplantation.
Raimondo ML; Dagher L; Papatheodoridis GV; Rolando N; Patch DW; Davidson BR; Rolles K; Burroughs AK
Transplantation; 2003 Jan; 75(2):186-90. PubMed ID: 12548120
[TBL] [Abstract][Full Text] [Related]
16. Mycophenolate mofetil for the treatment of acute and chronic steroid-refractory graft-versus-host disease.
Krejci M; Doubek M; Buchler T; Brychtova Y; Vorlicek J; Mayer J
Ann Hematol; 2005 Oct; 84(10):681-5. PubMed ID: 16001244
[TBL] [Abstract][Full Text] [Related]
17. Diabetic demyelinating polyneuropathy responsive to intravenous immunoglobulin therapy.
Sharma KR; Cross J; Ayyar DR; Martinez-Arizala A; Bradley WG
Arch Neurol; 2002 May; 59(5):751-7. PubMed ID: 12020256
[TBL] [Abstract][Full Text] [Related]
18. Mycophenolate mofetil in idiopathic membranous nephropathy: a clinical trial with comparison to a historic control group treated with cyclophosphamide.
Branten AJ; du Buf-Vereijken PW; Vervloet M; Wetzels JF
Am J Kidney Dis; 2007 Aug; 50(2):248-56. PubMed ID: 17660026
[TBL] [Abstract][Full Text] [Related]
19. Mycophenolate mofetil as an immunosuppressive agent in refractory inflammatory eye disease.
Choudhary A; Harding SP; Bucknall RC; Pearce IA
J Ocul Pharmacol Ther; 2006 Jun; 22(3):168-75. PubMed ID: 16808677
[TBL] [Abstract][Full Text] [Related]
20. Mycophenolate mofetil for the treatment of scleritis.
Sen HN; Suhler EB; Al-Khatib SQ; Djalilian AR; Nussenblatt RB; Buggage RR
Ophthalmology; 2003 Sep; 110(9):1750-5. PubMed ID: 13129873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]